Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Compendia Bioscience
    Registered Vendor
    • Feb 2012
    • 1

    Bioinformatics Engineer/NGS Specialist

    Compendia Bioscience was founded in 2006 with the understanding that managing the daily flood of new biological data and making it interpretable by scientists and physicians holds the key to the fight against cancer.

    We are currently looking for a Bioinformatics Engineer – NGS Specialist to join our team.

    Next generation sequencing is having a major impact on cancer research today. And in the future, it will likely directly impact cancer patient care. We are looking for a next generation sequencing data processing expert to join our team. Our ideal candidate is highly motivated, skilled, and dedicated. Your work will likely lead to important new discoveries waiting for us in this unprecedented data, and the delivery of these results to our customers may impact cancer patient care in important and meaningful ways.

    Responsibilities include:
    • Be part of a talented team of scientists and bioinformatics experts to help develop the infrastructure to process the growing number of NGS cancer samples available today
    • Design, prototype, test, and implement data pipelines that execute best-practice NGS data processing techniques, with an early emphasis on somatic gene mutations and gene fusions from Illumina and SOLiD, DNASeq and RNASeq, data
    • Collaborate with vendors to architect large-scale, cloud-based architectures capable of processing thousands of paired tumor-normal DNASeq exome samples, and tumor RNASeq samples, comprising hundreds of terabytes of raw data.
    • Create and implement a plan to process batches of patient samples using a standard job scheduling / grid engine package on the deployed cluster
    • Participate in the development of quality control and validation strategies, leading to the continual improvement of our processing pipelines and methods
    • Written and verbal presentation of scientific data results and methods

    Qualifications include:
    • Proven understanding of next generation sequencing technologies and data processing
    • Strong computational skills, particularly in large-scale data management, parallel processing architectures, Linux system administration, and cloud-based computing is desired
    • Outstanding written and verbal communication skills.
    • Previous bioinformatics and scientific programming experience necessary; experience with Spotfire, and Pipeline Pilot a plus.
    • Publications are highly valued.

    Our company is in Ann Arbor, MI. To submit your cover letter and resume, please go to our website at www.compendiabio.com

Latest Articles

Collapse

  • SEQadmin2
    Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
    by SEQadmin2


    Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

    The systematic characterization of the human proteome has
    ...
    07-20-2026, 11:48 AM
  • SEQadmin2
    Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
    by SEQadmin2



    Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
    ...
    07-09-2026, 11:10 AM
  • SEQadmin2
    Cancer Drug Resistance: The Lingering Barrier to Rising Survival
    by SEQadmin2



    Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

    There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
    07-08-2026, 05:17 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, Yesterday, 11:41 AM
0 responses
9 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-20-2026, 11:10 AM
0 responses
23 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-13-2026, 10:26 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 07-09-2026, 10:04 AM
0 responses
45 views
0 reactions
Last Post SEQadmin2  
Working...